Skip to main content
    S

    Sana Biotechnology Inc (SANA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.88
    -0.14 (-6.93%)

    Market Cap: $605.26M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sana Biotechnology Inc (SANA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Sana Biotechnology are Solid Biosciences LLC (SLDB), SAB Biotherapeutics (SABS) and Nautilus Biotechnology (NAUT). By market cap, Sana Biotechnology ranks 7th of the 13 companies on this page; Solid Biosciences LLC (SLDB) is the largest at $763.42M.

    Peer Comparison

    SANA's ROIC of -46.8% is below the peer median of -38.3%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Sana Biotechnology (SANA)$605.26MN/AN/A0.0%-46.8%0.0%0.00%
    Solid Biosciences LLC (SLDB)$763.42MN/AN/A0.0%N/A-100.0%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Nautilus Biotechnology Inc (NAUT)$295.50MN/A630.2x0.0%N/A0.0%0.00%
    Sagimet Biosciences Inc. Series A Common Stock (SGMT)$735.18MN/AN/A0.0%N/A0.0%0.00%
    Puma Biotechnology Inc (PBYI)$401.70M15.0x1.6x10.3%N/A1.1%0.00%
    Immix Biopharma Inc (IMMX)$657.09MN/AN/A0.0%-14.9%0.0%0.00%
    Ginkgo Bioworks Holdings (DNA)$622.97MN/A6.1x-192.0%N/A-5.7%0.00%
    Regenxbio Inc (RGNX)$505.18MN/A3.1x-113.9%N/A-69.2%0.00%
    Precision BioSciences Inc (DTIL)$288.76MN/A4.4x-85.6%-38.3%37272.0%0.00%
    Olema Pharmaceuticals Inc (OLMA)$662.30MN/AN/A0.0%-53.8%0.0%0.00%
    DiaMedica Therapeutics Inc (DMAC)$474.29MN/AN/A0.0%N/A0.0%0.00%
    Climb Bio Inc (CLYM)$608.53MN/AN/A0.0%N/A0.0%0.00%
    Peer median$556.85M15.0x4.4x0.0%-38.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Sana Biotechnology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Solid Biosciences LLC (SLDB)
    Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States.
    SLDB competitors
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Nautilus Biotechnology Inc (NAUT)
    Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome...
    NAUT competitors
    Sagimet Biosciences Inc. Series A Common Stock (SGMT)
    Sagimet Biosciences Inc. (SGMT) is an innovative biotechnology company focused on developing breakthrough treatments for metabolic diseases...
    SGMT competitors
    Puma Biotechnology Inc (PBYI)
    Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States...
    PBYI competitors
    Immix Biopharma Inc (IMMX)
    Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology...
    IMMX competitors
    Ginkgo Bioworks Holdings (DNA)
    Ginkgo Bioworks Holdings (DNA) is a pioneering force in synthetic biology, leveraging advanced genetic engineering to create customized bioengineered organisms...
    DNA competitors
    Regenxbio Inc (RGNX)
    REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable...
    RGNX competitors
    Precision BioSciences Inc (DTIL)
    Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States.
    DTIL competitors
    Olema Pharmaceuticals Inc (OLMA)
    Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development...
    OLMA competitors
    DiaMedica Therapeutics Inc (DMAC)
    DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
    DMAC competitors
    Climb Bio Inc (CLYM)
    Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases.
    CLYM competitors

    Frequently Asked Questions About SANA

    Who are Sana Biotechnology's main competitors?

    The companies most similar to Sana Biotechnology include Solid Biosciences LLC (SLDB), SAB Biotherapeutics (SABS), Nautilus Biotechnology (NAUT), Sagimet Biosciences Inc. Series A Common Stock (SGMT) and Puma Biotechnology (PBYI), listed from the closest match.

    Who is Sana Biotechnology's biggest competitor?

    Solid Biosciences LLC (SLDB) is both the largest of the similar companies at $763.42M and the closest match by business profile, size, sector and industry.

    How does SANA stock compare with its competitors?

    SANA's net margin is 0.0% against a peer median of 0.0%.

    Which of Sana Biotechnology's competitors pays a higher dividend?

    Sana Biotechnology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Sana Biotechnology bigger than its competitors?

    No. Sana Biotechnology is 7th by market cap among the 13 companies on this page; the largest is Solid Biosciences LLC (SLDB) at $763.42M.